ZEVRA THERAPEUTICS INC
ZVRA · NASDAQ
更新於 2026-10-13 14:47:33
$10.77-4.85%
- 今日最高
- $11.35
- 今日最低
- $10.71
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $11.39
- 昨天收盤價
- $11.32
- 成交量
- 509.03K
- 市值
- $569.87M
- 市盈率（P/E）
- 11.44X
- 每股收益（EPS）
- $0.96
昨天價格區間
$11.07$11.39
52週價格區間
$8.01$15.03
公司概況
- 板塊
- 醫療保健
- 行業
- 製藥
- 子行業
- 生物科技
- 總部
- 101 FEDERAL STREET, BOSTON, MA, 美國, 02110
- 國家
- 美國
- 上市日期
- 2015-04-16
- 財年截止
- 十二月
- 流通股數
- 59.12M
- CIK
- 0001434647
- 官方網址
- zevra.com
Zevra Therapeutics, Inc. 是一家罕見疾病公司，融合科學，在美國發現並開發多種專有前藥，用於治療嚴重疾病。公司總部位於佛羅里達州 Celebration。
財務指標
營業收入
2026-06-30
$39.66M
2026-03-31
$36.22M
2025-12-31
$34.12M
2025-09-30
$26.06M
營業支出
2026-06-30
$21.36M
2026-03-31
$25.17M
2025-12-31
$23.29M
2025-09-30
$20.36M
淨利潤
2026-06-30
$8.75M
2026-03-31
$37.89M
2025-12-31
$12.16M
2025-09-30
-$544K
淨利潤率
2026-06-30
22.06%
2026-03-31
104.61%
2025-12-31
35.64%
2025-09-30
-2.08%
每股收益
2026-06-30
$0.25
2026-03-31
$0.18
2025-12-31
$0.19
2025-09-30
$-0.01
息稅折舊攤銷前利潤
2026-06-30
$13.15M
2026-03-31
$43.46M
2025-12-31
$14.97M
2025-09-30
$1.46M
有效稅率
2026-06-30
31.59%
2026-03-31
15.43%
2025-12-31
3.95%
2025-09-30
44.31%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $39.66M | $36.22M | $34.12M | $26.06M |
| 營業支出 | $21.36M | $25.17M | $23.29M | $20.36M |
| 淨利潤 | $8.75M | $37.89M | $12.16M | -$544K |
| 淨利潤率 | 22.06% | 104.61% | 35.64% | -2.08% |
| 每股收益 | $0.25 | $0.18 | $0.19 | $-0.01 |
| 息稅折舊攤銷前利潤 | $13.15M | $43.46M | $14.97M | $1.46M |
| 有效稅率 | 31.59% | 15.43% | 3.95% | 44.31% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。